Company Profile A Subsidiary of Almarfa Corporation Kingdom of Saudi Arabia Solve Problems … … Add Values

Solve Problems Add Value Add Value Our core strategy is to deliver -to our market-the latest featured products with cutting edges Technology. A product that can solve a problem &/or add value to the overall clinical outcome.. We are committed to our core strategy as well as to our end-users and our business partners. Company Vision Company Core Strategy

A High Performance, Energetic Healthcare Supplier with Superior and Sustained Customer Support, dedicated for the introduction of the latest featured medical devices with cutting – edge – technologies. A device that can solve problems &/or add values for the whole clinical outcome, Utilizing our strong Financial Status and solid business expertise through our excellent staff to skim-off specially-targeted market niches in the healthcare industry. Company Vision

If You have a solid product portfolio which is quite innovative, well technically supported, well priced to be such competitive. If You have aggressive plans to leverage most of your company’s competences with enough tools to support your products. If You are equipped enough to help run a highly committed after-sales-support. If You are convinced with real mutual partnership with the concept of Shared Risk Strategy. You are then most welcome to be our life-long principal business partner. Jamal Abahussein Chairman Chairman’s Message

Company Offices Headquarters Main Warehouse Branch Manager Sales Management Service Head Dept. Peripheral Warehouse Main Router (MARBASE) Remote Router Riyadh Jeddah Dammam

Organizational Chart

Management Chairman Eng. Jamal Abahussein Bsc. Engineering, Executive MBA The Founder of Almarfa Medical, who consolidates the corporate infrastructure to reflect a streamlined business and he is the key of numerous operational initiatives. The man who provides the machinery for consultations and collaboration on the business and monetary scenario within Almarfa Group of Companies. With his top-notch internal audit and financial staff, is continuously focusing to augment the business portfolio within the group and collateral assets enhancement. As a Chairman, he is always offering the opportunities for all to utilize the corporate competencies in a productive way.

Business Portfolio Cardiac Surgery Off-Pump Cardiac Surgery Intv. Medicine Medical Projects General Surgery On-Pump Cardiac Surgery CVS - OR Vascular Surgery Interventional Cardiology Interventional Radiology PTSPTS Medical Equipment DisposablesDisposables EP-Electro-PhysiologyEP-Electro-Physiology Projects Management CVSCVS NIOBE- MAI

Business Partners Cardiovascular Surgery

Business Partners Interventional Medicine & EP

Business Partners Medical Projects Pneumatic Tubing System

Cardiovascular Programs Cardiac Assist Devices Program Beating Heart Surgery Program Minimally Invasive Cardiac Surgery Program Magnetic Navigation Intervention Program

New Product Introduction Policy  Target Product: it depends actually on: - Customers Actual Needs [ Customer Driven Policy ] - Expected Future Needs & Market Trends  Product Information Package: once the product has proven as a target, we will ask the manufacturer to present a complete information package for our review.  Product Accreditations: CE, FDA or other country-related accreditations.  Product References Evaluation: A reference list should be submitted for cross reference.  Current Competitors Evaluation: Competitors analysis is a very important step in approving a target product to be integrated to our portfolio. What’s the key FABs of this target product vs. competitors.  Product Manufacturer Evaluation: Target product manufacturer will be evaluated in respect of communication style, responsiveness, flexibility, seriousness, pricing, product support plans and after sales support proposal.  Launching Plan: At the time that all the above mentioned steps has fulfilled, the target product will be supported by Almarfa Medical for a swift delivery to the KOLs.  Demonstrations: With the first positive signs from our market’s KOLs, Almarfa Medical will call the manufacturer for a series of In-house presentations at the main reference centers for demonstrations and clinical workshops.  Intra-operative Evaluation: A further very important step, is to evaluate the target product intra-operatively as a mandatory step to be approved by the end user.  Feedback Verification: the final step is to achieve end user satisfaction and approval.  Decision Making : The target product now is integrated to our portfolio to enjoy our full support.

Almarfa Medical is enjoying a strong financial status. Our fully automated operation is ploughed to our strong financial poles. Despite of our strong financial relations with our bankers, we have never ever resorted to this mode of external borrowings. Our financial status could overcome any shortcoming in our operation.  Bank Reference 13 monthsTotal Cycle Time 9 monthsCollection Period 3 months Stock holding 1 monthTime of Declaration to our stores  Operating Cycle Financial Strengths Arab national bank P.O.Box : 41095, Riyadh 11521, Saudi Arabia The Manager, Commercial Banking Division Tel : Fax :

Business Milestones  The First Implantation of Totally-Implantable Artificial Heart; The first in Middle East, Asia, Africa & North America  The Giant Reference Hospital Pneumatic Tube System Project in the Middle East  The First Installation & Commissioning of NIOBE, Magnetic Navigation System in the Middle East.

Copyrights © 2013, Almarfa Medical Headquarters - Riyadh 405 Al Umam Commercial Centre, Siteen St. P.O.Box 28481, Riyadh 11437, Saudi Arabia Tel : Fax : Company Contact Addresses Branch Office - Dammam Almarfa Commercial Centre King Faisal St, P.O. Box Dammam 31516, Saudi Arabia Tel : Fax : Branch Office – Jeddah 105 Sharbatly Plaza, Hail Street, P.O. Box Jeddah 21313, Saudi Arabia Tel : Fax :

Copyrights © 2013, Almarfa Medical Thank You